387 related articles for article (PubMed ID: 19671596)
1. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model.
Mönckedieck V; Sannecke C; Husen B; Kumbartski M; Kimmig R; Tötsch M; Winterhager E; Grümmer R
Mol Hum Reprod; 2009 Oct; 15(10):633-43. PubMed ID: 19671596
[TBL] [Abstract][Full Text] [Related]
2. Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell.
Wahab M; Taylor AH; Pringle JH; Thompson J; Al-Azzawi F
Mol Hum Reprod; 2006 Mar; 12(3):157-67. PubMed ID: 16556677
[TBL] [Abstract][Full Text] [Related]
3. [Study of tissue morphology and vascular endothelial growth factor and matrix metalloproteinase-9 gene expressions in nude mouse endometriosis model].
Wang DB; Zhang SL; Niu HY; Lu JM
Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):759-62. PubMed ID: 15634503
[TBL] [Abstract][Full Text] [Related]
4. Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
Beranič N; Lanišnik Rižner T
Chem Biol Interact; 2013 Feb; 202(1-3):218-25. PubMed ID: 23183084
[TBL] [Abstract][Full Text] [Related]
5. [Effect of progesterone on the secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 in human ectopic endometrial stromal cells].
Chen JL; Lin QH; Fang XL; Tao GS; Huang FY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):307-11. PubMed ID: 16045020
[TBL] [Abstract][Full Text] [Related]
6. Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium.
Di Carlo C; Bonifacio M; Tommaselli GA; Bifulco G; Guerra G; Nappi C
Fertil Steril; 2009 Jun; 91(6):2315-23. PubMed ID: 18644593
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
[TBL] [Abstract][Full Text] [Related]
8. Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis.
Laschke MW; Elitzsch A; Scheuer C; Vollmar B; Menger MD
Fertil Steril; 2007 Jan; 87(1):163-71. PubMed ID: 17081538
[TBL] [Abstract][Full Text] [Related]
9. Progestin treatment induces apoptosis and modulates transforming growth factor-beta in the uterine endometrium.
Rodriguez GC; Rimel BJ; Watkin W; Turbov JM; Barry C; Du H; Maxwell GL; Cline JM
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):578-84. PubMed ID: 18349275
[TBL] [Abstract][Full Text] [Related]
10. Involvement of molecules related to angiogenesis, proteolysis and apoptosis in implantation in rhesus monkey and mouse.
Liu YX; Gao F; Wei P; Chen XL; Gao HJ; Zou RJ; Siao LJ; Xu FH; Feng Q; Liu K; Hu ZY
Contraception; 2005 Apr; 71(4):249-62. PubMed ID: 15792644
[TBL] [Abstract][Full Text] [Related]
11. Selectivity and potency of the retroprogesterone dydrogesterone in vitro.
Rižner TL; Brožič P; Doucette C; Turek-Etienne T; Müller-Vieira U; Sonneveld E; van der Burg B; Böcker C; Husen B
Steroids; 2011 May; 76(6):607-15. PubMed ID: 21376746
[TBL] [Abstract][Full Text] [Related]
12. Tibolone exerts progestational inhibition of matrix metalloproteinase expression in human endometrial stromal cells.
Schatz F; Kuczynski E; Kloosterbooer L; Krikun G; Buchwalder LF; Rahman M; Lockwood CJ
Steroids; 2006 Sep; 71(9):768-75. PubMed ID: 16806336
[TBL] [Abstract][Full Text] [Related]
13. Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis.
Hull ML; Prentice A; Wang DY; Butt RP; Phillips SC; Smith SK; Charnock-Jones DS
Hum Reprod; 2005 Feb; 20(2):350-8. PubMed ID: 15567877
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget.
Bruner-Tran KL; Zhang Z; Eisenberg E; Winneker RC; Osteen KG
J Clin Endocrinol Metab; 2006 Apr; 91(4):1554-60. PubMed ID: 16418212
[TBL] [Abstract][Full Text] [Related]
15. Effects of tumor necrosis factor-alpha on cell proliferation, prostaglandins and matrix-metalloproteinases production in rat endometrial stromal cells cultured in vitro.
Gamo T; Yamauchi N; Nishimura K; Watanabe R; Matsumoto K; Oozono S; Kubota K; He PJ; Soh T; Hattori MA
J Exp Zool A Ecol Genet Physiol; 2007 Dec; 307(12):699-707. PubMed ID: 17963241
[TBL] [Abstract][Full Text] [Related]
16. Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptor with the estrogen receptors and kinase signaling pathways.
Vicent GP; Ballaré C; Zaurin R; Saragüeta P; Beato M
Ann N Y Acad Sci; 2006 Nov; 1089():59-72. PubMed ID: 17261755
[TBL] [Abstract][Full Text] [Related]
17. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium.
Schindler AE
Maturitas; 2009 Dec; 65 Suppl 1():S3-11. PubMed ID: 19969432
[TBL] [Abstract][Full Text] [Related]
18. Testosterone inhibits matrix metalloproteinase-1 production in human endometrial stromal cells in vitro.
Ishikawa T; Harada T; Kubota T; Aso T
Reproduction; 2007 Jun; 133(6):1233-9. PubMed ID: 17636177
[TBL] [Abstract][Full Text] [Related]
19. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis.
Osteen KG; Bruner-Tran KL; Eisenberg E
Fertil Steril; 2005 Mar; 83(3):529-37. PubMed ID: 15749474
[TBL] [Abstract][Full Text] [Related]
20. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
